No definition available.
Congenital malformations of the nervous system
DOID EFO Endpoint Browser PheWeb
Q17_CONGEN_MALFO_NERVOUS_SYSTEM
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
796 |
4. Check minimum number of eventsNone |
796 |
5. Include endpoints |
863 |
6. Filter based on genotype QC (FinnGen only) |
863 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q
- Name in latin
- Malformationes congenitae systematis nervosi
Similar endpoints
↥List of similar endpoints to
Congenital malformations of the nervous system
based on the number of shared cases.
Similar with more cases:
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 10956 | 5699 | 5233 |
| Only index persons | 8283 | 4517 | 3766 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.15 | 0.16 | 0.15 |
| Only index persons | 0.16 | 0.17 | 0.14 |
| Median age at first event (years) | |||
| Whole population | 10.11 | 14.17 | 5.54 |
| Only index persons | 14.66 | 19.57 | 8.77 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 863 | 580 | 283 |
| Unadjusted period prevalence (%) | 0.17 | 0.20 | 0.12 |
| Median age at first event (years) | 28.62 | 30.37 | 25.04 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 765
- Matched controls
- 7647
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q07.0
ICD-10 Finland
Arnold-Chiari syndrome
+∞
323.0
293
*
ABE50
NOMESCO Finland
Occipitocervical decompression
+∞
99.1
93
*
Q04.8
ICD-10 Finland
Other specified congenital malformations of brain
+∞
72.0
68
*
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
112.2
57.7
62
6
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
8.0
56.4
137
204
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
6.2
53.3
158
310
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
5.8
49.8
155
321
Q04.6
ICD-10 Finland
Congenital cerebral cysts
+∞
49.5
47
*
G95.0
ICD-10 Finland
Syringomyelia and syringobulbia
133.5
47.4
50
*
AA1AD
NOMESCO Finland
CT of head and brain
4.2
46.0
206
623
R51.80
ICD-10 Finland
Headache
3.8
45.2
230
778
G91.1
ICD-10 Finland
Obstructive hydrocephalus
50.5
43.5
52
11
N03AF02
ATC
oxcarbazepine; oral
9.6
41.7
88
102
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
11.3
40.5
78
76
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
8.6
39.9
90
117
Q05.2
ICD-10 Finland
Lumbar spina bifida with hydrocephalus
+∞
36.8
35
*
Q03.9
ICD-10 Finland
Congenital hydrocephalus, unspecified
+∞
36.8
35
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
8.5
35.4
80
104
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
37.8
34.1
43
12
N03AX14
ATC
levetiracetam; systemic
9.0
34.0
74
90
7423A
ICD-9 Finland
Other congenital anomalies of nervous system, Congenital hydrocephalus
+∞
31.5
30
*
74200
ICD-8 Finland
Congenital hydrocephalus, Communicans
+∞
30.4
29
*
183
Kela drug reimbursment
Lamotrigin and topiramate
13.5
30.3
53
42
G91.0
ICD-10 Finland
Communicating hydrocephalus
43.1
30.2
37
9
Q05.7
ICD-10 Finland
Lumbar spina bifida without hydrocephalus
+∞
28.3
27
*
Q07.8
ICD-10 Finland
Other specified congenital malformations of nervous system
+∞
28.3
27
*
Q03.0
ICD-10 Finland
Malformations of aqueduct of Sylvius
+∞
28.3
27
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
13.7
28.3
49
38
2133
FHL
Suntin revisio
280.3
26.9
27
*
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
30.5
26.5
35
12
7410D
ICD-9 Finland
Spina bifida, With hydrocephalus[SPINA BIFIDA APERTA CUM HYDROCEPHALO REG LUMBALIS]
+∞
26.2
25
*
Q05.9
ICD-10 Finland
Spina bifida, unspecified
+∞
26.2
25
*
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
75.0
25.9
29
*
N05BA09
ATC
clobazam; oral
12.5
25.5
46
39
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
13.7
25.5
44
34
74209
ICD-8 Finland
Congenital hydrocephalus, Unspecified
+∞
25.1
24
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.6
24.2
116
357
N03AX11
ATC
topiramate; oral
6.8
23.7
61
96
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
55.8
23.2
27
5
Q02
ICD-10 Finland
Microcephaly
+∞
23.0
22
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.9
22.7
100
285
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
12.7
22.5
40
33
XA800
NOMESCO Finland
Neuropsychological investigation
4.4
22.1
84
209
Z01.8
ICD-10 Finland
Other specified special examinations
2.6
21.8
191
876
G93.0
ICD-10 Finland
Cerebral cysts
23.0
21.8
31
14
N03AX12
ATC
gabapentin; oral
3.2
21.7
125
439
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.9
21.7
152
611
H47.2
ICD-10 Finland
Optic atrophy
32.2
21.6
28
9
XKC03
NOMESCO Finland
Water cystometry
8.3
21.0
47
60
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
79.0
20.8
23
*
AAF99
NOMESCO Finland
Other shunt operation on ventricle of brain or intracerebral cyst
113.1
20.7
22
*
Q06.8
ICD-10 Finland
Other specified congenital malformations of spinal cord
+∞
19.9
19
*
N03AX18
ATC
lacosamide; systemic
16.9
19.8
31
19
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
19.7
207
1038
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
11.0
19.6
37
35
R56.8
ICD-10 Finland
Other and unspecified convulsions
4.0
19.5
81
219
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
15.3
19.0
31
21
Q04.9
ICD-10 Finland
Congenital malformation of brain, unspecified
+∞
18.8
18
*
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
28.6
18.8
25
9
N03AG01
ATC
valproic acid; systemic, rectal
3.8
18.8
82
232
R42
ICD-10 Finland
Dizziness and giddiness
2.6
18.5
154
681
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.6
18.1
87
266
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
14.1
17.9
30
22
N05BA01
ATC
diazepam; systemic, rectal
2.9
17.7
113
425
ZXE20
NOMESCO Finland
More than three and less than five hours
2.8
17.6
123
488
2132
FHL
Ventricular operators sunt
184.0
17.6
18
*
N03AF01
ATC
carbamazepine; oral, rectal
5.6
17.6
52
99
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
17.0
233
1308
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
13.8
16.6
28
21
XKD06
NOMESCO Finland
Physiologic investigation of micturition
8.3
16.4
36
45
R20.2
ICD-10 Finland
Paraesthesia of skin
3.7
16.4
74
215
N03AX16
ATC
pregabalin; oral
2.4
16.4
156
737
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
7.7
16.1
37
50
AA1AA
NOMESCO Finland
Head X-ray examination
13.9
16.1
27
20
G04BD04
ATC
oxybutynin; oral, transdermal
5.1
16.0
51
106
Q04.3
ICD-10 Finland
Other reduction deformities of brain
+∞
15.7
15
*
TAB00
NOMESCO Finland
Lumbar puncture
4.6
15.6
55
127
G91.8
ICD-10 Finland
Other hydrocephalus
86.9
15.6
17
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
15.4
270
1661
F83
ICD-10 Finland
Mixed specific developmental disorders
6.0
15.0
41
71
UKC02
NOMESCO Finland
Cystoscopy
3.0
15.0
90
324
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
57.8
14.8
17
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.3
14.7
76
247
Q07.9
ICD-10 Finland
Congenital malformation of nervous system, unspecified
+∞
14.6
14
*
N03AX09
ATC
lamotrigine; oral
3.4
14.6
73
231
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.5
14.5
52
123
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.9
14.4
47
101
G44.2
ICD-10 Finland
Tension-type headache
2.4
14.3
129
588
N05CD08
ATC
midazolam; nasal, systemic
5.6
13.8
40
75
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.6
13.7
63
186
G40.10
ICD-10 Finland
Simple partial seizures
15.1
13.6
22
15
R4110
NOMESCO Finland
Physiotherapy
2.0
13.6
203
1163
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
8.6
13.6
29
35
7419D
ICD-9 Finland
Spina bifida, Without mention of hydrocephalus[SPINA BIFIDA APERTA SINE HYDROCEPHALO REG LUMBALIS]
+∞
13.6
13
*
Q04.00
ICD-10 Finland
Agenesis of corpus callosum
+∞
13.6
13
*
Q05.0
ICD-10 Finland
Cervical spina bifida with hydrocephalus
+∞
13.6
13
*
3313A
ICD-9 Finland
Other cerebral degenerations, Communicating hydrocephalus
142.4
13.5
14
*
M03BX01
ATC
baclofen; systemic
7.2
13.5
32
46
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.5
13.3
108
466
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.0
13.3
80
288
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
13.2
284
1853
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.8
13.0
84
318
N31.0
ICD-10 Finland
Uninhibited neuropathic bladder, not elsewhere classified
23.0
12.9
18
8
G96.0
ICD-10 Finland
Cerebrospinal fluid leak
50.9
12.9
15
*
L89
ICD-10 Finland
Decubitus ulcer and pressure area
11.8
12.9
23
20
R4120
NOMESCO Finland
Occupational therapy
3.1
12.7
71
242
N03AX15
ATC
zonisamide; oral
15.7
12.7
20
13
Q01.8
ICD-10 Finland
Encephalocele of other sites
+∞
12.5
12
*
Q05.8
ICD-10 Finland
Sacral spina bifida without hydrocephalus
+∞
12.5
12
*
N03AX22
ATC
perampanel; oral
20.4
12.5
18
9
Z3226
NOMESCO Finland
Physiotherapist
2.1
12.5
165
897
N02AX02
ATC
tramadol; systemic, rectal
1.9
12.4
234
1456
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.6
12.2
92
378
R62.0
ICD-10 Finland
Delayed milestone
4.8
12.2
40
87
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
18.4
12.1
18
10
AAF00
NOMESCO Finland
Ventriculostomy
18.4
12.1
18
10
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
27.2
12.1
16
6
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
5.3
12.0
36
71
XKD00
NOMESCO Finland
Uroflowmetry
2.9
11.8
73
268
N03AE01
ATC
clonazepam; systemic
3.6
11.8
53
155
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
16.7
11.7
18
11
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.6
11.6
88
364
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
9.4
11.5
23
25
Q06.9
ICD-10 Finland
Congenital malformation of spinal cord, unspecified
+∞
11.5
11
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.4
11.4
56
175
G04AC01
ATC
NA
4.8
11.3
37
80
S18
ICPC
Laceration/cut
1.8
11.3
255
1671
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
11.2
98
440
H50.1
ICD-10 Finland
Divergent concomitant strabismus
10.2
11.0
21
21
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.6
11.0
85
356
3454A
ICD-9 Finland
Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]
44.0
10.9
13
*
SPAT1229
SPAT
Assessment of need for aid
3.8
10.9
46
128
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
8.4
10.9
23
28
J01EA01
ATC
trimethoprim; systemic
1.9
10.8
177
1038
M41.4
ICD-10 Finland
Neuromuscular scoliosis
18.1
10.8
16
9
G04BD07
ATC
tolterodine; oral
4.8
10.7
35
76
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
10.7
136
724
Z31.5
ICD-10 Finland
Genetic counselling
2.7
10.7
73
283
204
Kela drug reimbursment
Leukemia lymphatica
4.6
10.7
36
81
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.6
10.6
79
323
1530
FHL
Urethrocystoscopy
9.3
10.6
21
23
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
10.2
10.5
20
20
Z2445
NOMESCO Finland
Psychologist
2.6
10.5
76
306
R15
ICD-10 Finland
Faecal incontinence
7.5
10.5
24
33
L28
ICPC
Limited function/disability (L)
2.5
10.5
85
365
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.2
10.5
114
567
Q03.1
ICD-10 Finland
Atresia of foramina of Magendie and Luschka
+∞
10.4
10
*
74101
ICD-8 Finland
Spina bifida, Cum hydrocephalo, non cute tecta
+∞
10.4
10
*
74190
ICD-8 Finland
Spina bifida, Hydrocephalo non indicato, cute tecta
+∞
10.4
10
*
AAJ20
NOMESCO Finland
Excision of epileptic focus
+∞
10.4
10
*
74201
ICD-8 Finland
Congenital hydrocephalus, Non communicans
+∞
10.4
10
*
74210
ICD-8 Finland
NA
+∞
10.4
10
*
KA1AE
NOMESCO Finland
Kidney ultrasound examination
5.6
10.3
29
53
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.1
10.3
56
189
G40
ICD-10 Finland
Epilepsy
9.7
10.3
20
21
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.9
10.2
63
230
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.6
10.1
45
131
N28
ICPC
Limited function/disability (N)
8.6
10.1
21
25
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
10.0
239
1583
Q66.0
ICD-10 Finland
Talipes equinovarus
14.8
10.0
16
11
N06AX21
ATC
duloxetine; oral
2.5
9.9
81
349
SPAT1216
SPAT
Assessment of functional ability
2.4
9.9
82
358
R51
ICD-10 Finland
Headache
2.7
9.6
64
246
A02BC02
ATC
pantoprazole; systemic
1.6
9.6
367
2763
TKC22
NOMESCO Finland
Catheterisation instruction
8.5
9.6
20
24
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
8.5
9.6
20
24
A02BC01
ATC
omeprazole; systemic
1.9
9.6
164
971
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
15.3
9.5
15
10
R33
ICD-10 Finland
Retention of urine
4.1
9.4
36
92
AAF40
NOMESCO Finland
Shunt of cyst of brain to peritoneum
101.2
9.4
10
*
3314A
ICD-9 Finland
Other cerebral degenerations, Obstructive hydrocephalus
101.2
9.4
10
*
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
17.8
9.4
14
8
7424A
ICD-9 Finland
Other congenital anomalies of nervous system, Other specified anomalies of brain
+∞
9.4
9
*
Q05.3
ICD-10 Finland
Sacral spina bifida with hydrocephalus
+∞
9.4
9
*
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
9.3
142
806
G47.3
ICD-10 Finland
Sleep apnoea
2.1
9.3
112
578
A28
ICPC
Limited function/disability NOS
2.6
9.2
69
286
J01XE01
ATC
nitrofurantoin; oral
5.7
9.1
25
45
TJF80
NOMESCO Finland
Ostomy education
8.4
9.1
19
23
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
11.6
9.1
16
14
R11
ICD-10 Finland
Nausea and vomiting
2.3
9.0
83
380
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
4.0
8.9
34
87
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
24.3
8.9
12
5
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.8
8.9
59
225
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.2
8.9
90
432
H53.4
ICD-10 Finland
Visual field defects
6.0
8.8
23
39
F82
ICD-10 Finland
Specific developmental disorder of motor function
4.8
8.8
28
60
Z2446
NOMESCO Finland
Social worker
2.2
8.8
92
450
ADB00
NOMESCO Finland
Implantation of vagus nerve stimulating device
16.5
8.6
13
8
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
6.1
8.5
22
37
G03.9
ICD-10 Finland
Meningitis, unspecified
20.3
8.5
12
6
74199
ICD-8 Finland
Spina bifida, Without mention of hydrocephalus
91.0
8.4
9
*
S06.0
ICD-10 Finland
Concussion
2.1
8.4
92
459
P85
ICPC
Mental retardation
8.0
8.4
18
23
Y83.1
ICD-10 Finland
Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
12.9
8.4
14
11
R1250
NOMESCO Finland
Evaluation of functional capability
5.1
8.4
25
50
Q04.08
ICD-10 Finland
Congenital malformations of corpus callosum
+∞
8.3
8
*
Q00.0
ICD-10 Finland
Anencephaly
+∞
8.3
8
*
Q01.1
ICD-10 Finland
Nasofrontal encephalocele
+∞
8.3
8
*
74100
ICD-8 Finland
Spina bifida, Cum hydrocephalo, cute tecta
+∞
8.3
8
*
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
9.6
8.3
16
17
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
9.6
8.3
16
17
H52.2
ICD-10 Finland
Astigmatism
4.3
8.3
29
69
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
14.7
8.2
13
9
NHL14
NOMESCO Finland
Shortening or lengthening of achilles tendon
14.7
8.2
13
9
G04BD08
ATC
solifenacin; oral
3.6
8.1
35
101
N88
ICPC
Epilepsy
9.0
8.1
16
18
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
8.0
318
2385
N03AX23
ATC
brivaracetam; systemic
22.3
8.0
11
5
AAF15
NOMESCO Finland
Ventriculoatrial shunt
22.3
8.0
11
5
WX110
NOMESCO Finland
Local anesthesy
1.6
8.0
527
4461
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.3
7.9
75
351
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
5.2
7.9
23
45
G43.9
ICD-10 Finland
Migraine, unspecified
2.4
7.8
68
302
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.7
7.8
168
1066
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
7.1
7.8
18
26
WX402
NOMESCO Finland
General anaesthesia
1.8
7.7
136
810
Z3231
NOMESCO Finland
Registered nurse
1.6
7.7
211
1439
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
7.7
147
903
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
2.1
7.7
84
419
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.8
7.7
129
759
ZXD05
NOMESCO Finland
Urgent procedure
1.6
7.6
229
1596
N06AX16
ATC
venlafaxine; oral
1.9
7.6
108
598
N03AG04
ATC
vigabatrin; oral
12.0
7.6
13
11
KH1EE
NOMESCO Finland
Urologic ultrasound examination
12.0
7.6
13
11
J01MA02
ATC
ciprofloxacin; systemic
1.6
7.6
206
1400
R5140
NOMESCO Finland
Monitoring the use of the aid
2.5
7.5
58
245
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.8
7.5
45
165
H50.0
ICD-10 Finland
Convergent concomitant strabismus
5.1
7.5
22
44
XCK00
NOMESCO Finland
Perimetry
2.9
7.4
43
153
AAK40
NOMESCO Finland
Closure of cerebrospinal fluid fistula
80.8
7.4
8
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.1
7.4
82
410
H53.2
ICD-10 Finland
Diplopia
4.1
7.3
27
68
H50.31
ICD-10 Finland
Intermittent exotropia
5.0
7.3
22
45
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.9
7.3
43
155
TJD20
NOMESCO Finland
Change of gastrostomy tube
6.9
7.3
17
25
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.9
7.3
114
652
ABE99
NOMESCO Finland
Other operation for spinal malformation
+∞
7.3
7
*
Q03.88
ICD-10 Finland
Other congenital hydrocephalus
+∞
7.3
7
*
74191
ICD-8 Finland
Spina bifida, Hydrocephalo non indicato, non ente tecta
+∞
7.3
7
*
7410B
ICD-9 Finland
Spina bifida, With hydrocephalus[SPINA BIFIDA APERTA CUM HYDROCEPHALO REG CERVIC]
+∞
7.3
7
*
G44.8
ICD-10 Finland
Other specified headache syndromes
5.9
7.3
19
33
H01AC01
ATC
somatropin; parenteral
4.5
7.2
24
55
KDV20
NOMESCO Finland
Submucous urethral injection
30.3
7.2
9
*
R32
ICD-10 Finland
Unspecified urinary incontinence
4.6
7.1
23
51
SPAT1153
SPAT
Removal of sutures
1.7
7.1
166
1079
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
4.4
7.1
24
56
ZXA00
NOMESCO Finland
Right side
1.8
7.1
140
866
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.1
7.0
82
421
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
6.4
7.0
17
27
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
6.9
104
587
F71.0
ICD-10 Finland
Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour
13.9
6.9
11
8
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
13.9
6.9
11
8
M05BB03
ATC
alendronic acid and colecalciferol; oral
8.4
6.8
14
17
N02BE01
ATC
paracetamol; systemic, rectal
1.5
6.8
543
4698
181
Kela drug reimbursment
Retigabine and vigabatrin
11.1
6.8
12
11
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
9.4
6.8
13
14
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.6
6.8
47
186
XX1XW
NOMESCO Finland
Extensive written report from radiologist
5.7
6.8
18
32
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
4.4
6.8
23
54
F72.0
ICD-10 Finland
Severe mental retardation, with the statement of no, or minimal, impairment of behaviour
16.9
6.8
10
6
N99
ICPC
Neurological disease other
7.3
6.7
15
21
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
6.7
119
710
SPAT1260
SPAT
Consultation of another employee
1.8
6.7
121
729
R52.2
ICD-10 Finland
Other chronic pain
3.6
6.6
28
80
N06AA09
ATC
amitriptyline; systemic
2.5
6.6
50
210
G40.00
ICD-10 Finland
Benign childhood epilepsy with centrotemporal EEG spikes
8.8
6.6
13
15
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
6.6
287
2173
ZXA05
NOMESCO Finland
Left side
1.7
6.5
127
781
R4130
NOMESCO Finland
Speech therapy
3.6
6.4
27
77
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
7.5
6.4
14
19
ZXY02
NOMESCO Finland
Neuropsychologist
8.2
6.3
13
16
ZXE00
NOMESCO Finland
One hour or less
1.5
6.3
288
2194
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
9.4
6.3
12
13
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
6.3
171
1155
M41.5
ICD-10 Finland
Other secondary scoliosis
18.2
6.3
9
5
SPAT1301
SPAT
No procedures
1.6
6.3
206
1461
Q06.3
ICD-10 Finland
Other congenital cauda equina malformations
+∞
6.3
6
*
M49.4*G95.0
ICD-10 Finland
Neuropathic spondylopathy in syringomyelia and syringobulbia
+∞
6.3
6
*
G00.8
ICD-10 Finland
Other bacterial meningitis
+∞
6.3
6
*
Q04.4
ICD-10 Finland
Septo-optic dysplasia
+∞
6.3
6
*
3360A
ICD-9 Finland
Other diseases of spinal cord, Syringomyelia and syringobulbia
+∞
6.3
6
*
T85.7
ICD-10 Finland
Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts
+∞
6.3
6
*
2139
FHL
Other measure in this category
+∞
6.3
6
*
A06AD11
ATC
lactulose; oral
2.1
6.2
67
331
R5110
SPAT
NA
5.4
6.2
17
32
N29
ICPC
Neurological sympt/complt other
4.3
6.2
21
50
H13
ICPC
Plugged feeling ear
1.9
6.1
85
468
Q89.7
ICD-10 Finland
Multiple congenital malformations, not elsewhere classified
12.6
6.1
10
8
-
ICD-10 Finland
NA
4.4
6.1
20
46
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
466
2929
2.28
30.81
10.5
7.9
mmol/l
1.2
1.2
0.86
409
2550
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
433
2666
2.25
29.78
9.8
8.0
mmol/l
1.2
1.2
1.58
404
2467
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
78
199
4.21
27.89
1.8
3.3
mg/l
646.5
403.9
1.30
73
190
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
46
75
6.42
27.32
2.6
2.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
31
37
8.65
24.13
1.6
1.6
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
68
183
3.95
22.57
1.7
3.3
mmol/l
3.5
3.5
0.01
63
173
(3044290) Cell count panel - Cerebral spinal fluid
65
174
3.96
21.72
1.9
3.8
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
31
43
7.44
21.31
2.1
2.7
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
266
1502
2.11
21.13
2.5
2.1
u/l
218.0
228.5
0.05
252
1432
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
67
193
3.68
20.16
2.0
3.5
e6/l
41.7
7.1
0.93
51
138
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
67
193
3.68
20.16
2.0
3.5
e6/l
167.3
264.8
0.47
54
143
(3024561) Albumin [Mass/volume] in Serum or Plasma
361
2350
1.92
18.70
5.1
5.3
g/l
37.4
36.9
1.06
331
2208
(3016018) Differential panel - Cerebral spinal fluid
43
94
4.76
18.62
1.9
4.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
117
493
2.59
18.21
7.8
10.5
mmol/l
0.6
0.8
0.20
79
382
(3013826) Glucose [Moles/volume] in Serum or Plasma
501
3662
1.88
17.79
6.5
5.5
mmol/l
6.0
6.3
4.04
479
3331
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
316
2003
1.91
17.47
1.9
1.7
pmol/l
98.7
97.0
0.26
179
1068
(3019550) Sodium [Moles/volume] in Serum or Plasma
785
6767
2.77
17.37
17.8
11.8
mmol/l
139.4
139.6
0.74
770
6576
(3023103) Potassium [Moles/volume] in Serum or Plasma
785
6785
2.74
16.93
17.4
11.8
mmol/l
3.9
3.9
0.37
767
6570
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
391
2732
1.79
15.26
2.9
2.6
nmol/l
75.9
72.8
0.81
366
2540
(3044640) Blood type and Crossmatch panel - Blood
306
2006
1.81
14.65
2.6
2.4
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
32
70
4.71
13.86
6.5
9.5
mg/l
10.0
9.6
0.12
27
65
(3032080) INR in Blood by Coagulation assay
293
1922
1.79
13.84
6.0
6.2
inr
1.2
1.1
0.34
87
609
(3020891) Body temperature
53
169
3.28
13.65
5.1
5.7
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
257
1636
1.81
13.34
4.1
5.2
%
94.6
92.8
0.65
247
1587
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
582
4661
1.76
13.29
6.6
6.6
u/l
83.6
84.5
0.13
556
4380
(3015377) Calcium [Moles/volume] in Serum or Plasma
285
1898
1.75
12.54
2.8
2.9
mmol/l
2.4
2.4
0.11
255
1705
(3013650) Neutrophils [#/volume] in Blood by Automated count
521
4110
1.68
11.93
8.1
9.6
e9/l
4.0
3.9
0.44
466
3542
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
116
583
2.14
11.91
6.2
5.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
138
742
2.02
11.84
1.6
1.7
nmol/l
1144.8
1173.7
0.15
110
574
(3036481) Cortisol [Moles/volume] in Serum or Plasma
135
726
2.02
11.56
2.1
2.2
nmol/l
383.5
360.1
0.64
120
680
(3008152) Bicarbonate [Moles/volume] in Arterial blood
64
250
2.68
11.52
11.1
9.1
mmol/l
24.3
24.2
0.11
58
231
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
239
1548
1.75
11.42
2.5
2.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
264
1761
1.72
11.35
4.9
2.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
173
1020
1.87
11.28
1.5
1.6
pmol/l
58865701.2
38600893.3
0.13
141
886
(3023368) Bacteria identified in Blood by Culture
213
1340
1.78
11.23
4.6
4.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
243
1609
1.71
10.62
4.6
3.7
ph
7.4
7.4
1.27
47
284
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
401
3018
1.61
10.59
5.0
6.3
umol/l
11.8
13.8
0.82
373
2845
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
45
152
3.07
10.56
2.1
2.4
ug/l
667.7
227.7
0.93
36
137
(3026782) Osmolality of Urine
196
1223
1.78
10.56
4.3
2.6
mosm/kgh2o
540.1
568.1
0.86
177
1047
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
801
7295
2.36
10.10
9.9
8.8
u/l
25.5
26.4
0.79
787
7075
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
307
2190
1.62
9.94
5.1
3.1
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
462
3638
1.58
9.80
6.4
6.9
e9/l
0.0
0.0
0.09
410
3126
(3021960) Folate [Moles/volume] in Serum or Plasma
181
1126
1.77
9.78
1.6
1.4
nmol/l
21.6
21.0
0.17
157
973
(3001604) Monocytes [#/volume] in Blood
461
3631
1.58
9.75
6.4
6.9
e9/l
0.6
0.5
0.43
409
3122
(3023410) Appearance of Cerebral spinal fluid
37
117
3.26
9.69
1.9
4.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
60
248
2.53
9.66
8.1
6.7
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
644
5526
1.65
9.20
4.6
3.9
pmol/l
14.6
14.4
0.81
600
5115
(3019198) Lymphocytes [#/volume] in Blood
471
3763
1.55
9.10
6.4
6.9
e9/l
2.1
2.1
0.05
424
3310
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
233
1585
1.64
8.97
2.4
2.4
mg/l
3.0
2.8
0.67
201
1374
(3013336) Amino acids [Identifier] in Serum or Plasma
13
18
7.32
8.86
1.8
4.0
—
—
—
0
0
(3044889) 12 lead EKG panel
487
3954
1.53
8.50
3.1
2.9
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
468
3769
1.53
8.47
6.9
7.4
e9/l
0.2
0.2
0.08
424
3300
(3000850) Epithelial cells [#/volume] in Urine
195
1285
1.67
8.44
4.1
2.4
e6/l
5.7
7.5
1.28
176
1116
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
394
3069
1.52
8.27
4.2
4.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
135
809
1.79
8.20
2.5
1.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
125
736
1.82
8.04
7.9
7.5
mmol/l
1.9
1.4
0.86
99
575
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
161
1021
1.71
8.01
4.2
2.7
e6/l
1.1
1.0
0.21
99
530
(3013707) Erythrocyte sedimentation rate by Westergren method
571
4846
1.53
7.74
4.3
3.8
mm/h
9.4
9.3
0.12
546
4518
(3000991) Gas panel - Venous blood
115
668
1.83
7.72
8.2
10.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
713
6394
1.66
7.34
5.3
4.5
mu/l
1.7
2.0
0.90
669
6019
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
248
1805
1.52
6.88
3.4
2.9
ng/l
15.9
28.0
1.93
140
929
(3015171) Extractable nuclear Ab [Units/volume] in Serum
56
262
2.22
6.88
1.4
1.2
u/ml
0.2
0.9
—
7
14
(3018677) aPTT in Platelet poor plasma by Coagulation assay
139
884
1.68
6.79
2.4
4.3
s
28.4
30.2
4.29
130
864
(3003458) Phosphate [Moles/volume] in Serum or Plasma
139
886
1.68
6.73
9.6
8.2
mmol/l
1.2
1.2
0.05
131
842
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
24
73
3.35
6.73
1.0
1.2
mg/l
64.5
33.6
0.83
19
56
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
135
855
1.69
6.70
2.1
1.9
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
133
840
1.69
6.66
2.0
2.4
mmol/l
2.4
2.4
0.06
114
732
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
107
636
1.78
6.65
14.7
7.6
mmol/l
1.1
1.1
0.00
74
456
(3030467) Casts [#/volume] in Urine by Automated count
239
1741
1.52
6.56
5.3
3.0
e6/l
0.2
0.3
0.37
192
1264
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
26
85
3.12
6.51
1.1
1.1
—
—
—
0
0
(3009343) pH of Capillary blood
108
651
1.75
6.40
14.6
7.5
ph
7.4
7.4
—
7
40
(3012095) Magnesium [Moles/volume] in Serum or Plasma
143
932
1.64
6.34
4.9
5.9
mmol/l
0.8
0.8
0.07
134
884
(3011397) Hemoglobin [Presence] in Urine by Test strip
220
1587
1.52
6.29
4.8
3.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
799
7467
1.94
6.26
15.2
9.7
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
244
1802
1.49
6.22
2.6
2.6
u/l
52.8
55.0
0.47
223
1684
(36304419) Bacteria [Presence] in Urine
236
1734
1.50
6.17
5.4
3.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
208
1496
1.51
6.00
5.0
3.2
kg/l
1.0
1.0
0.40
34
211
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
148
987
1.60
5.97
4.7
2.8
e6/l
3.2
2.8
0.20
88
499
(3002582) Erythrocytes [#/volume] in Urine
252
1897
1.46
5.78
5.6
3.0
e6/l
20.9
105.3
1.48
205
1409
(40761535) Cells panel - Urine sediment
74
410
1.88
5.77
3.7
3.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
33
132
2.56
5.76
1.7
1.6
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
13
28
4.70
5.75
2.3
2.4
umol/l
27.1
17.5
1.32
13
28
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
613
5420
1.45
5.69
4.7
4.4
mmol/mol
36.7
38.1
4.15
570
5117
(3029937) Albumin [Presence] in Urine by Test strip
238
1780
1.47
5.62
5.4
3.4
estimate
0.0
0.0
1.08
78
657
(3022096) Basophils/100 leukocytes in Blood
406
3346
1.40
5.59
6.8
7.1
%
0.6
0.7
2.13
387
3157
(3042936) Bacteria identified in Isolate by Culture
123
801
1.62
5.45
2.5
2.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
765
7108
1.67
5.43
16.8
11.0
mg/l
20.3
20.7
0.16
642
5353
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
80
466
1.79
5.33
1.2
1.2
—
29.2
—
0
19
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
18
53
3.45
5.33
6.1
4.8
ug/l
1.9
1.9
0.03
18
53
(42870588) Differential panel, method unspecified - Blood
308
2438
1.41
5.28
6.8
7.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
414
3448
1.39
5.24
5.2
3.2
estimate
0.0
0.0
0.80
81
646
(40758558) Short blood count panel - Blood
244
1855
1.44
5.23
5.8
7.6
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
20
64
3.18
5.21
1.1
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
409
3409
1.38
5.11
5.1
3.1
estimate
0.0
0.0
0.00
79
644
(3019069) Monocytes/100 leukocytes in Blood
417
3487
1.38
5.10
6.9
7.2
%
8.1
8.2
0.23
400
3307
(4027681)
20
65
3.13
5.09
1.2
1.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
414
3460
1.38
5.07
6.6
7.0
%
2.6
2.9
1.80
394
3256
(3021601) Nitrite [Presence] in Urine by Test strip
409
3413
1.38
5.05
6.8
4.4
estimate
0.0
0.0
0.42
77
667
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
23
82
2.85
5.01
1.0
1.0
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
152
1065
1.52
4.89
3.1
3.8
ng/l
996.4
881.2
0.21
125
871
(3001122) Ferritin [Mass/volume] in Serum or Plasma
420
3540
1.36
4.78
3.3
2.9
ug/l
73.8
79.0
0.36
397
3335
(40767503) Oxygen content in Capillary blood by calculation
26
102
2.60
4.75
2.3
2.4
%
16.7
16.8
0.04
16
54
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
90
561
1.67
4.73
2.5
3.3
g/l
0.2
0.2
0.22
81
534
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
197
1464
1.45
4.72
1.9
2.5
mg/l
0.8
1.2
1.12
150
1074
(3005719) IgG [Mass/volume] in Serum or Plasma
94
594
1.65
4.69
3.2
3.1
g/l
9.8
9.9
0.11
85
551
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
17
53
3.25
4.63
1.1
1.3
—
—
—
0
0
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
9
11
8.25
4.57
2.6
3.0
umol/l
21.4
28.3
—
9
11
(3049233) Organic acids panel - Urine
9
11
8.25
4.57
1.2
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
86
535
1.67
4.56
13.7
7.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
294
2358
1.37
4.52
6.3
3.6
e6/l
87.6
73.7
0.15
219
1521
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
95
609
1.63
4.49
1.9
1.8
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
421
3579
1.34
4.41
6.4
6.7
%
54.6
54.3
0.18
402
3398
(3023323) Follitropin [Units/volume] in Serum or Plasma
88
559
1.64
4.32
1.6
1.7
iu/l
20.4
20.5
0.01
68
453
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
95
616
1.61
4.29
2.1
1.9
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
66
389
1.75
4.26
1.6
1.8
u/l
7.8
8.4
0.18
45
299
(3037467) Urinalysis macro (dipstick) panel - Urine
531
4689
1.34
4.23
6.0
3.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
318
2609
1.35
4.15
5.2
3.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
656
5994
1.39
4.15
4.0
3.4
mmol/l
5.6
5.7
1.06
605
5563
(3002030) Lymphocytes/100 leukocytes in Blood
423
3623
1.33
4.10
6.7
6.9
%
31.0
31.2
0.12
401
3435
(3010015) Selenium [Moles/volume] in Serum or Plasma
10
23
4.39
4.09
2.3
2.8
umol/l
1.0
1.1
—
10
23
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
47
3.23
4.07
1.1
1.3
—
—
—
0
0
(4024509)
13
37
3.55
4.06
1.2
1.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
56
320
1.80
4.02
2.1
3.2
g/l
66.5
66.8
0.15
50
299
(3006184) Hemoglobin [Mass/volume] in Capillary blood
28
124
2.30
4.00
2.0
2.4
g/l
137.5
133.0
0.38
21
96
(3047181) Lactate [Moles/volume] in Blood
31
144
2.20
3.97
9.3
8.8
mmol/l
1.7
1.2
0.38
23
123
(40768797) Stomach Pathology biopsy report
112
770
1.52
3.93
1.2
1.3
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
86
557
1.60
3.91
8.2
7.9
mmol/l
23.9
23.7
0.26
80
533
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
32
152
2.15
3.88
1.8
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
26
114
2.32
3.81
3.9
3.1
—
—
—
0
0
(3013512) EKG study
177
1339
1.40
3.79
3.2
3.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
390
3328
1.31
3.78
9.7
9.4
e9/l
0.0
0.0
0.35
324
2647
(3022948) Iron [Moles/volume] in Serum or Plasma
127
908
1.47
3.69
3.0
2.4
umol/l
13.5
14.3
0.64
118
846
(3022217) INR in Platelet poor plasma by Coagulation assay
74
471
1.62
3.63
18.1
13.7
inr
1.3
1.2
—
7
75
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
31
150
2.11
3.61
1.9
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
213
1679
1.36
3.53
5.2
4.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
53
860
0.59
3.45
1.5
1.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
278
2291
1.31
3.38
3.5
3.5
u/l
29.0
31.0
0.47
261
2185
(3014271) Vancomycin [Susceptibility]
9
18
5.04
3.37
3.2
2.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
23
478
0.47
3.37
1.6
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
135
998
1.42
3.28
1.3
1.4
titre
430.8
535.4
0.34
26
185
(3011048) Pyruvate [Moles/volume] in Blood
9
19
4.77
3.24
1.6
1.3
umol/l
102.7
93.8
—
9
19
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
64
405
1.63
3.23
6.7
3.3
mmol/l
1.2
1.2
0.26
55
347
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
77
510
1.56
3.22
2.9
2.7
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
14
49
2.89
3.20
1.0
1.1
u/l
1.3
1.1
—
6
21
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
20
85
2.39
3.17
2.8
4.0
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
105
746
1.46
3.16
3.4
2.6
%
21.7
23.5
0.68
93
660
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
62
392
1.63
3.15
2.2
1.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
636
5873
1.32
3.12
11.0
8.9
ml/min/173m2
99.2
93.1
8.65
539
4620
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
48
285
1.72
3.08
1.7
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
22
99
2.25
3.08
2.2
3.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
114
830
1.43
3.02
3.2
2.4
g/l
2.5
2.4
0.26
106
768
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
93
652
1.48
3.00
1.3
1.2
iu/ml
99.1
154.3
1.16
30
273
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
5
10.05
2.98
1.2
1.4
—
—
—
0
0
(3019225) pH of Specimen
68
448
1.56
2.93
2.9
3.9
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
835
8115
1.89
2.87
23.3
16.3
e9/l
6.8
6.7
0.59
825
7880
(3007461) Platelets [#/volume] in Blood
834
8105
1.86
2.83
23.3
16.3
e9/l
267.3
261.5
1.83
825
7896
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
28
145
1.96
2.78
2.2
1.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
83
580
1.48
2.73
2.1
2.4
u/l
24.7
115.6
0.55
71
482
(3026361) Erythrocytes [#/volume] in Blood
834
8112
1.84
2.71
23.3
16.2
e12/l
4.5
4.6
0.53
823
7883
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
29
154
1.91
2.68
2.5
2.1
ug/l
0.4
3.1
0.92
24
139
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
52
329
1.62
2.67
1.6
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
23
438
0.51
2.65
1.4
1.5
—
—
—
0
0
(3032641) Amino acids panel - Urine
5
7
7.18
2.55
1.2
1.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
17
353
0.47
2.54
1.4
1.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
69
472
1.50
2.53
2.9
2.3
e9/l
4.0
4.2
0.27
54
402
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
19
88
2.19
2.52
3.0
3.9
%
11.4
10.4
0.16
13
72
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
7
16
4.40
2.48
2.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
24
440
0.53
2.47
1.4
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
42
257
1.67
2.47
11.3
14.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
24
439
0.53
2.45
1.4
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
24
439
0.53
2.45
1.4
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
34
561
0.59
2.41
1.4
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
38
228
1.70
2.40
2.0
2.6
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
9
27
3.36
2.39
1.1
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
18
358
0.49
2.39
1.4
1.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
49
315
1.59
2.38
2.3
2.2
ug/l
7.2
6.6
0.06
42
282
(3002179) Metamyelocytes/100 leukocytes in Blood
66
456
1.48
2.33
4.0
4.6
%
0.2
0.5
1.18
14
104
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
28
3.24
2.31
1.0
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
28
3.24
2.31
1.1
1.3
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
9
28
3.24
2.31
1.0
1.1
—
10.5
—
0
7
(3005322) IgE [Units/volume] in Serum or Plasma
82
593
1.42
2.29
1.6
1.3
u/ml
498.8
238.8
0.29
73
553
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
53
2.48
2.28
1.2
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
18
351
0.50
2.26
1.4
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
213
2523
0.79
2.26
2.3
2.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
16
73
2.21
2.22
1.3
1.3
nmol/l
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
112
860
1.35
2.19
3.2
3.8
ug/l
1.5
2.1
0.80
103
779
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
146
1165
1.30
2.19
1.3
1.3
iu/ml
25.8
26.5
0.03
51
346
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
31
181
1.74
2.18
1.6
1.8
—
—
—
0
0
(4010399)
57
388
1.50
2.17
1.3
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
34
204
1.69
2.17
1.9
2.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
11
43
2.58
2.10
1.8
2.3
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
21
110
1.93
2.07
6.3
2.9
kpa
4.9
4.9
0.03
21
110
(3012501) Base excess in Blood by calculation
21
110
1.93
2.07
6.3
2.9
mmol/l
1.6
2.3
0.92
14
68
(3027315) Oxygen [Partial pressure] in Blood
21
110
1.93
2.07
6.3
2.9
kpa
9.1
9.2
0.10
21
110
(3022621) pH of Urine by Test strip
55
376
1.49
2.06
3.4
2.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
70
502
1.43
2.06
5.2
4.8
%
0.4
0.9
1.65
20
147
(21494755) Public health laboratory ask at order entry panel
74
999
0.72
2.03
1.3
1.3
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
8
26
3.10
2.01
1.0
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
19
97
1.98
2.01
7.0
3.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
30
178
1.71
2.01
2.7
3.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
229
1952
1.24
1.99
1.7
1.5
g/l
1.9
2.0
0.37
140
1154
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
7
21
3.35
1.97
1.0
1.0
nmol/l
86.7
108.0
—
7
14
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
8
27
2.98
1.94
1.1
1.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
20
106
1.91
1.92
2.9
3.6
e9/l
1.5
1.5
0.01
15
61
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
19
99
1.94
1.91
1.8
1.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
66
476
1.42
1.90
5.4
4.9
%
0.1
0.1
0.57
17
132
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
6
17
3.55
1.84
1.5
1.5
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
6
17
3.55
1.84
4.0
2.6
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
5
12
4.18
1.82
1.4
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
5
12
4.18
1.82
3.8
3.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
34
216
1.60
1.79
1.9
2.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
203
1727
1.23
1.78
3.9
3.4
mmol/l
7.3
8.3
1.90
184
1507
(3027945) Reticulocytes/100 erythrocytes in Blood
81
614
1.35
1.75
2.8
4.9
%
1.4
1.6
1.73
72
568
(3048689) Calprotectin [Mass/mass] in Stool
142
1163
1.26
1.75
2.4
2.7
ug/g
140.9
98.7
0.84
105
921
(4034850)
31
194
1.62
1.74
10.8
8.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
27
163
1.68
1.73
1.4
1.4
u/l
16.8
19.3
0.17
22
142
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
58
792
0.71
1.72
1.6
1.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
13
61
2.15
1.72
1.5
4.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
13
3.86
1.71
3.0
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
99
776
1.31
1.71
2.7
3.9
umol/l
4.8
6.6
1.59
88
648
(4094501)
21
118
1.80
1.71
1.1
1.1
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
16
82
1.97
1.70
1.3
1.3
nmol/l
0.7
0.5
0.41
16
77
(3021387) Prolactin [Units/volume] in Serum or Plasma
65
478
1.39
1.70
1.3
1.6
mu/l
339.2
310.4
0.28
58
435
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
23
380
0.59
1.70
2.1
1.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
42
285
1.50
1.67
1.3
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
509
4733
1.18
1.66
3.7
3.1
u/l
43.2
37.1
0.77
480
4521
(3020876) Protein [Mass/time] in 24 hour Urine
8
31
2.60
1.66
2.6
2.5
—
2.0
—
0
5
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
8
31
2.60
1.66
3.3
4.3
ug/l
197.9
125.4
—
8
31
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
33
213
1.57
1.64
1.5
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
123
1499
0.79
1.64
1.8
1.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
250
2189
1.20
1.63
1.3
1.5
u/ml
1.0
2.2
1.93
68
534
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
27
424
0.63
1.63
1.5
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
61
450
1.38
1.58
1.2
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
45
314
1.46
1.58
2.0
3.6
ng/l
76.5
153.1
2.04
37
283
(3049717) Cytology report of Urine Cyto stain
21
122
1.74
1.55
1.6
2.0
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
13
64
2.05
1.54
1.9
3.3
umol/l
26.0
27.2
0.19
13
64
(40768804) Tissue Pathology biopsy report
274
2432
1.19
1.53
1.9
1.9
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
10
205
0.48
1.52
1.7
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
43
0.00
1.52
0.0
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
27
2.61
1.51
2.3
1.8
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
7
27
2.61
1.51
1.4
1.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
7
27
2.61
1.51
1.0
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
7
27
2.61
1.51
1.4
1.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
21
2.87
1.50
1.3
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
39
268
1.48
1.49
1.9
1.6
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
6
22
2.74
1.43
1.2
1.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
39
271
1.46
1.42
1.7
1.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
40
561
0.70
1.42
1.4
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
667
6390
1.19
1.38
18.7
14.0
%
13.4
13.4
0.40
658
6278
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
41
2.21
1.37
1.4
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
31
207
1.52
1.37
1.6
1.7
u/ml
100.3
101.3
0.02
11
28
(3025159) Blasts/100 leukocytes in Blood
60
454
1.35
1.36
5.8
5.0
%
0.0
0.2
1.18
13
111
(4035726)
59
446
1.35
1.35
1.4
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
9
42
2.15
1.34
2.7
1.7
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
24
2.51
1.30
2.3
1.8
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
18
2.79
1.28
2.4
3.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
41
295
1.41
1.26
1.2
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
36
501
0.71
1.24
1.6
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
85
685
1.27
1.24
3.7
3.6
%
22.1
21.2
0.20
37
255
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
14
78
1.81
1.21
1.2
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
160
1839
0.84
1.20
1.8
1.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
57
438
1.32
1.19
2.8
4.0
e9/l
65.1
70.1
0.56
36
305
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
26
2.32
1.19
2.3
1.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
17
102
1.68
1.17
2.4
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
729
7070
1.20
1.16
16.7
12.5
%
40.0
40.1
0.21
552
5904
(46235355) HIV 1 and 2 tests - Meaningful Use set
206
2312
0.86
1.16
2.1
2.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
40
292
1.39
1.15
2.8
2.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
15
87
1.74
1.15
1.8
1.3
—
—
—
0
0
(4062490)
15
87
1.74
1.15
1.3
1.3
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
13
72
1.82
1.15
2.0
8.7
mmol/l
5.5
6.5
1.38
13
58
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
20
2.51
1.15
1.0
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
13
73
1.79
1.11
2.2
1.8
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
23
339
0.67
1.10
1.6
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
160
1395
1.18
1.10
2.2
2.9
umol/l
319.6
4490.4
4.00
141
1251
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
21
2.39
1.09
1.6
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
21
2.39
1.09
1.6
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
20
128
1.58
1.09
1.5
1.8
—
—
—
0
0
(3003338) MCHC [Mass/volume]
688
6655
1.17
1.05
19.3
14.1
g/l
333.5
333.6
0.07
688
6610
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
42
315
1.35
1.05
12.5
13.2
mg/l
1.1
1.1
0.01
42
301
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
20
130
1.55
1.03
2.5
2.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
10
53
1.90
1.01
1.6
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
18
115
1.58
1.00
2.9
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
217
1955
1.15
0.98
4.4
2.8
—
—
—
0
0
(3036489) Thrombin time
43
328
1.33
0.97
2.7
5.4
s
21.4
22.3
0.71
38
297
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
34
250
1.37
0.97
1.6
1.6
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
10
54
1.86
0.97
2.2
2.2
pg
32.0
32.7
—
10
54
(3048929) Epstein Barr virus Ab [Presence] in Serum
57
454
1.27
0.95
1.5
1.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
9
51
1.77
0.94
1.8
4.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
33
243
1.37
0.94
4.1
2.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
27
2.23
0.93
2.3
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
27
2.23
0.93
2.3
1.9
—
—
—
0
0
(3000012) Reticulocyte production index
6
27
2.23
0.93
1.5
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
58
465
1.27
0.92
2.3
2.2
nmol/l
11.6
12.2
0.19
48
421
(3033705) Calcium.ionized [Moles/volume] in Venous blood
9
52
1.74
0.92
1.4
2.7
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
9
52
1.74
0.92
1.4
2.7
mmol/l
3.9
4.0
—
9
52
(3035285) Chloride [Moles/volume] in Venous blood
9
52
1.74
0.92
1.4
2.7
mmol/l
105.6
106.1
—
9
52
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
10
55
1.83
0.92
1.1
1.1
—
0.5
—
0
6
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
19
126
1.52
0.92
1.0
1.2
—
—
—
0
0
(4146454)
6
28
2.15
0.91
2.3
3.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
28
2.15
0.91
2.3
1.9
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
72
594
1.23
0.90
3.4
3.3
%
31.1
31.6
0.14
57
423
(3042111) Morphology [Interpretation] in Bone marrow Narrative
12
71
1.70
0.89
1.8
2.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
75
623
1.22
0.88
2.1
1.9
—
—
—
0
0
(44813793)
11
64
1.73
0.86
1.0
1.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
110
951
1.18
0.86
3.4
3.4
ng/l
254.4
612.9
0.91
63
577
(3000494) Fungus identified in Specimen by Culture
85
718
1.20
0.85
1.6
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
20
137
1.47
0.84
2.8
1.8
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
32
1.88
0.82
2.2
3.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
24
173
1.40
0.79
1.1
1.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
6
33
1.82
0.79
1.0
1.6
nmol/l
3.6
4.2
—
6
33
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
48
1.67
0.79
1.3
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
8
48
1.67
0.79
1.3
1.1
%
87.5
86.2
—
8
48
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
26
0.00
0.78
0.0
8.0
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
21
148
1.43
0.78
1.9
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
21
148
1.43
0.78
1.9
1.3
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
33
252
1.32
0.77
1.2
1.4
—
8.1
—
0
8
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
34
1.77
0.76
2.3
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
34
1.77
0.76
2.3
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
34
1.77
0.76
2.3
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
34
1.77
0.76
2.3
1.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
50
405
1.25
0.76
2.8
2.4
ml/min/173m2
67.7
77.3
0.81
21
160
(3027923) C peptide [Moles/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
2.0
—
1.0
—
0
23
(3011288) Drugs identified in Urine by Screen method
52
424
1.24
0.75
2.6
2.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
126
1115
1.15
0.75
1.3
1.2
u/ml
10.2
9.9
0.02
52
445
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
24
2.09
0.74
8.6
5.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
74
627
1.20
0.74
2.1
1.9
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
7
38
1.85
0.73
1.3
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
20
142
1.42
0.73
6.4
10.3
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
39
1.80
0.72
3.0
1.7
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
9
56
1.61
0.72
3.6
2.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
646
6275
1.12
0.72
4.0
3.8
mmol/l
2.8
2.8
0.55
605
5902
(3028300) Cannabinoids [Presence] in Urine
74
629
1.19
0.72
2.1
1.9
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
37
291
1.28
0.72
1.5
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
642
6235
1.12
0.72
3.7
3.6
mmol/l
4.6
4.7
1.89
605
5904
(40761536) Microorganisms panel - Urine sediment
71
602
1.20
0.71
6.1
3.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
74
630
1.19
0.71
3.1
2.3
u/l
3050.0
4476.8
0.27
22
262
(3020682) Albumin/Creatinine [Ratio] in Urine
144
1292
1.14
0.71
3.9
4.1
mg/mmol
5.3
9.4
1.21
94
846
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
5
26
1.93
0.70
1.2
1.1
u/ml
81.1
37.9
—
5
26
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
5
26
1.93
0.70
1.6
5.5
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
22
296
0.74
0.69
1.1
1.2
u/ml
6.8
6.0
0.09
14
198
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
7
42
1.67
0.68
1.0
1.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
136
1.41
0.67
1.2
2.1
g/l
6.7
7.3
1.01
14
112
(3024980) IgG subclass 4 [Mass/volume] in Serum
19
136
1.41
0.67
1.2
1.8
g/l
1.4
0.8
0.74
13
108
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
136
1.41
0.67
1.2
2.1
g/l
3.5
3.7
0.21
13
105
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
136
1.41
0.67
1.2
2.1
—
—
—
0
0
(4281824)
7
43
1.63
0.67
1.0
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
28
1.79
0.66
2.8
1.9
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
28
1.79
0.66
1.4
2.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
111
1.45
0.66
2.1
1.7
—
—
—
0
0
(1002224) Polysomnography panel
38
304
1.26
0.66
1.1
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
12
78
1.55
0.65
1.9
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
15
103
1.46
0.65
1.7
2.5
ug/min
216.8
99.0
—
7
64
(36660697) Celiac disease serology panel - Serum
94
824
1.16
0.65
1.2
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
28
216
1.31
0.64
1.0
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
29
1.73
0.64
1.4
1.4
nmol/l
155.2
152.3
—
5
29
(3005988) Vibrio sp identified in Specimen by Organism specific culture
12
79
1.53
0.63
1.9
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
12
79
1.53
0.63
1.9
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
12
79
1.53
0.63
1.9
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
12
79
1.53
0.63
1.9
1.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
26
200
1.31
0.61
2.5
1.9
iu/l
7.4
5.1
0.19
11
70
(3012516) Albumin [Mass/volume] in Urine
136
1230
1.13
0.60
3.6
3.4
mg/l
641.4
218.1
0.40
93
824
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
141
0.63
0.60
1.3
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
51
1.57
0.60
2.5
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
8
51
1.57
0.60
2.0
3.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
8
51
1.57
0.60
1.9
1.7
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31
245
1.28
0.60
1.7
1.6
u/ml
253.9
205.3
0.38
19
129
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
15
209
0.71
0.60
1.8
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
12
80
1.51
0.60
1.9
1.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
22
288
0.76
0.60
1.1
1.2
u/ml
1.1
4.1
—
10
88
(3047007) Chlamydophila sp Ab [Presence] in Serum
22
166
1.33
0.59
1.1
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
22
286
0.76
0.57
1.1
1.2
u/ml
1.0
0.5
—
10
173
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
73
1.51
0.56
1.9
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
10
65
1.54
0.55
1.1
1.2
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
10
65
1.54
0.55
2.5
2.3
nmol/l
0.2
0.1
—
10
45
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
6
37
1.63
0.55
1.2
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
37
1.63
0.55
1.0
1.1
miu/ml
1415.0
1493.4
—
6
37
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
13
90
1.45
0.55
2.4
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
32
394
0.80
0.55
1.6
1.9
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
58
497
1.18
0.55
2.3
2.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
115
1038
1.12
0.54
1.9
1.7
%
1.5
1.4
0.88
100
949
(3000570) Elastase.pancreatic [Mass/mass] in Stool
22
170
1.30
0.52
1.2
1.4
ug/g
374.3
342.4
0.30
14
93
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
609
5939
1.09
0.51
3.3
3.2
mmol/l
1.2
1.2
0.03
567
5609
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
18
135
1.34
0.51
1.4
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
41
1.47
0.50
1.0
1.0
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
23
180
1.29
0.50
1.4
1.2
u/ml
34.0
12.0
—
5
29
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
24
189
1.28
0.50
3.7
1.9
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
634
6198
1.09
0.49
3.6
3.5
mmol/l
1.4
1.5
1.22
594
5851
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
24
191
1.26
0.47
3.3
1.9
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
40
338
1.19
0.46
1.4
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
51
586
0.86
0.44
1.1
1.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
130
1.31
0.44
3.6
15.0
u/ml
0.3
0.4
—
9
77
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
11
78
1.42
0.43
1.5
1.7
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
5
31
1.62
0.43
3.0
3.5
—
—
—
0
0
(4211845)
5
31
1.62
0.43
2.8
1.8
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
27
327
0.82
0.42
1.1
1.2
u/ml
3.3
2.2
0.22
13
179
(3006598) pH of Arterial cord blood
6
94
0.64
0.42
1.0
1.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
18
140
1.29
0.42
1.7
1.3
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
33
1.52
0.41
2.8
1.7
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
15
0.00
0.41
0.0
2.7
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
16
0.00
0.41
0.0
2.8
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
11
79
1.40
0.41
1.5
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
30
357
0.83
0.40
2.5
4.2
ug/l
3.4
20.8
0.77
22
277
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
18
0.00
0.40
0.0
1.2
—
9.4
—
0
18
(3002256) Pathology report gross observation
79
713
1.12
0.40
1.3
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
48
548
0.87
0.39
1.3
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
8
61
1.31
0.39
1.6
1.4
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
7
104
0.67
0.39
1.4
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
173
1840
0.93
0.39
2.5
2.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
106
0.66
0.39
1.0
1.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
157
1676
0.92
0.39
2.5
2.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
19
0.00
0.39
0.0
6.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
17
133
1.28
0.38
4.6
3.9
e9/l
3.8
4.1
0.21
17
133
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
5
36
1.39
0.38
2.2
2.4
—
1401.0
—
0
5
(3029075) Extractable nuclear Ab panel - Serum
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
36
1.39
0.38
2.4
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
69
621
1.12
0.37
2.1
1.8
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
9
69
1.31
0.37
1.0
1.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
42
1.43
0.35
1.5
3.3
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
18
144
1.26
0.35
1.7
1.8
pmol/l
171.4
209.3
0.73
18
136
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
17
135
1.26
0.35
5.9
4.2
%
54.6
55.4
0.09
17
135
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
6
43
1.40
0.35
1.5
1.2
—
79.3
—
0
7
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
43
1.40
0.35
1.2
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
44
1.37
0.34
3.5
1.5
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
25
209
1.20
0.34
1.4
1.6
—
266.7
—
0
6
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
11
82
1.35
0.34
3.5
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
49
435
1.13
0.33
1.2
1.2
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
11
83
1.33
0.32
1.0
1.0
g/l
1.6
1.4
1.14
11
74
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
92
1.31
0.32
2.4
5.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
27
230
1.18
0.31
1.2
1.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
17
138
1.24
0.30
1.4
1.2
—
1.1
—
0
9
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
7
54
1.30
0.30
1.7
1.6
g/l
1.0
1.1
—
7
54
(3038177) Helicobacter pylori Ab [Presence] in Serum
16
129
1.24
0.30
1.3
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
133
1412
0.93
0.30
1.6
1.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
10
75
1.34
0.30
1.3
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
15
120
1.25
0.30
6.3
3.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
46
514
0.89
0.30
2.0
2.5
ug/l
0.5
0.7
1.90
31
275
(3016879) Cocaine [Presence] in Urine
64
583
1.11
0.29
2.2
1.9
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
31
355
0.87
0.29
1.5
1.7
mg/l
5.7
2.8
0.89
20
233
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
13
162
0.80
0.28
1.3
2.2
mg/l
8.3
10.5
0.75
13
148
(3045424) Erythrocytes [Presence] in Urine
14
112
1.25
0.28
1.4
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
10
76
1.32
0.28
11.7
15.3
%
12.7
12.0
—
10
76
(3025018) Bordetella pertussis Ab [Titer] in Serum
12
94
1.28
0.28
1.3
1.2
—
—
—
0
0
(3000492) Spirometry study
63
686
0.91
0.27
1.4
1.3
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
8
66
1.21
0.26
1.5
2.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
21
178
1.18
0.26
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
72
0.69
0.26
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
72
0.69
0.26
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
72
0.69
0.26
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
72
0.69
0.26
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
72
0.69
0.26
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
73
0.68
0.26
1.0
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
29
330
0.87
0.25
1.4
1.8
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
27
235
1.15
0.25
1.2
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
17
142
1.20
0.24
1.1
2.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
10
125
0.80
0.23
1.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
26
228
1.14
0.23
1.2
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
160
1533
1.05
0.22
1.6
1.7
mmol/l
1.3
1.4
0.62
146
1334
(3014148) Varicella zoster virus Ab [Titer] in Serum
12
146
0.82
0.22
1.2
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
10
124
0.80
0.21
2.6
2.6
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(44806071)
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
79
841
0.93
0.21
1.8
2.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
104
0.77
0.21
1.1
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
43
1.16
0.21
2.0
2.4
u/ml
309.6
705.3
—
5
43
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
20
173
1.16
0.21
1.5
1.9
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
13
0.00
0.21
0.0
1.8
—
1447.8
—
0
8
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
36
397
0.90
0.20
1.2
1.3
miu/ml
192.8
256.4
0.50
17
203
(3023487) Leukocytes [#/volume] in Peritoneal fluid
0
14
0.00
0.20
0.0
2.5
—
654.4
—
0
14
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
10
122
0.82
0.19
1.4
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
7
61
1.15
0.17
1.0
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
122
1170
1.05
0.17
1.7
1.6
—
—
—
0
0
(4198724)
7
63
1.11
0.17
1.4
1.8
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
53
566
0.93
0.16
1.1
1.2
—
93.7
—
0
18
(3045142) Bone marrow Pathology biopsy report
8
71
1.13
0.16
2.1
1.5
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
8
71
1.13
0.16
1.3
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
11
130
0.84
0.16
1.1
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
66
624
1.06
0.15
1.3
1.3
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
6
79
0.76
0.15
1.3
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
80
0.75
0.15
1.3
1.8
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
25
226
1.11
0.15
1.2
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
14
121
1.16
0.15
1.2
1.2
%
120.7
113.0
0.48
14
111
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
83
1.09
0.14
1.6
1.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
25
227
1.10
0.14
1.2
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
128
0.86
0.13
1.2
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
19
211
0.90
0.13
1.0
1.1
u/ml
8.0
9.7
0.14
11
96
(3008898) HLA-B27 [Presence]
36
385
0.93
0.12
1.0
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
23
251
0.91
0.12
1.6
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
28
259
1.08
0.11
2.6
2.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
12
105
1.14
0.11
1.1
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
12
105
1.14
0.11
3.2
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
96
1.15
0.10
1.5
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
49
467
1.05
0.10
1.8
1.8
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
5
46
1.09
0.09
6.0
7.6
g/mol
82.2
85.5
—
5
37
(40768441) Liver Pathology biopsy report
5
48
1.04
0.09
1.4
1.7
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
12
134
0.89
0.08
1.1
1.2
u/ml
2.8
5.8
—
6
53
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
56
1.07
0.08
2.3
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
56
1.07
0.08
2.3
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
56
1.07
0.08
2.3
1.8
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
56
1.07
0.08
7.5
1.9
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
57
1.05
0.08
2.7
4.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
10
113
0.88
0.08
1.2
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
10
113
0.88
0.08
1.6
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
61
0.82
0.08
1.8
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
65
1.08
0.08
1.0
1.1
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
16
174
0.92
0.07
1.7
1.3
pmol/l
45.4
65.3
1.94
16
169
(3003694) ABO and Rh group [Type] in Blood
242
2388
1.02
0.07
1.6
1.7
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
17
184
0.92
0.07
1.0
1.1
u/ml
4.4
0.3
—
6
63
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
7
81
0.86
0.07
3.0
1.6
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
9
88
1.02
0.07
1.1
1.1
%
98.0
92.8
—
9
82
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
155
1524
1.02
0.06
1.6
1.5
—
—
—
0
0
(44806118)
13
119
1.09
0.06
3.2
1.9
—
—
—
0
0
(44790049)
13
119
1.09
0.06
3.2
1.9
—
—
—
0
0
(44790047)
13
119
1.09
0.06
3.2
1.9
—
—
—
0
0
(44790048)
13
119
1.09
0.06
3.2
1.9
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
15
139
1.08
0.05
1.9
1.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
30
287
1.05
0.05
1.4
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
94
924
1.02
0.04
2.1
1.9
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
17
160
1.06
0.04
1.2
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
115
1136
1.01
0.03
2.2
2.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
234
2325
1.01
0.02
2.0
1.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
23
239
0.96
0.02
1.7
1.5
iu/ml
0.0
0.0
0.21
11
43
(3021879) Hepatitis B virus core Ab [Presence] in Serum
71
721
0.98
0.02
1.3
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
19
198
0.96
0.02
1.1
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
622
6228
1.00
0.01
3.7
3.8
—
—
—
0
0
(4306422)
12
114
1.05
0.00
1.2
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
12
126
0.95
0.00
3.2
3.5
mg/l
37.9
27.7
—
5
87
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
10
104
0.96
0.00
1.8
1.6
mmol/l
7.3
7.3
—
5
68
(40768793) Breast Pathology biopsy report
14
144
0.97
0.00
1.4
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
27
266
1.02
0.00
4.4
5.2
g/l
0.2
0.3
0.65
13
154
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
34
338
1.01
0.00
1.3
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
31
309
1.00
0.00
1.2
1.4
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
19
189
1.01
0.00
1.0
1.1
u/ml
2.4
7.1
1.90
12
94
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
36
357
1.01
0.00
2.0
2.1
u/ml
23.6
36.6
0.82
36
341
(3014599) Egg white IgE Ab [Units/volume] in Serum
12
115
1.04
0.00
1.2
1.3
u/ml
2.4
4.4
—
7
64
(3015183) Erythrocyte sedimentation rate
5
55
0.91
0.00
1.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
89
0.90
0.00
1.4
1.5
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.3
—
16.1
—
0
8
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
65.7
—
0
6
(3033799) Differential panel - Peritoneal fluid
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
7
73
0.96
0.00
1.3
1.5
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
6
0.00
0.00
0.0
3.7
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
5
51
0.98
0.00
2.2
3.0
u/ml
15.2
71.6
—
5
51
(3003157) Bacteria [#/volume] in Mother's milk
0
5
0.00
0.00
0.0
6.2
—
—
—
0
0
(4038314)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
6
69
0.87
0.00
1.0
1.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
64
0.94
0.00
1.3
1.1
—
—
—
0
0
(44806420)
0
9
0.00
0.00
0.0
2.7
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
8.1
—
0
5
(3018081) Beta-2-Microglobulin [Mass/volume] in Urine
0
5
0.00
0.00
0.0
2.2
—
9.5
—
0
5
(4015189)
0
7
0.00
0.00
0.0
3.4
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
9
95
0.95
0.00
1.8
1.3
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(4268621)
9
91
0.99
0.00
2.0
2.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
6
62
0.97
0.00
2.0
1.8
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
5.8
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
7
69
1.01
0.00
1.1
1.3
—
339.1
—
0
11
(3022475) Manganese [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
0
5
0.00
0.00
0.0
2.0
—
462.6
—
0
5
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
7
73
0.96
0.00
5.7
4.5
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.6
—
0.5
—
0
5
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
72
0.97
0.00
2.0
1.2
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_CONGEN_MALFO_NERVOUS_SYSTEM and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CONGEN_MALFO_NERVOUS_SYSTEM | 2.691 [2.25, 3.23] | < 0.001 |
| Birth year | 0.994 [0.99, 1.0] | 0.139 |
During the follow-up period (1.1.1998 — 31.12.2019), 237 out of 4093 females with Q17_CONGEN_MALFO_NERVOUS_SYSTEM died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CONGEN_MALFO_NERVOUS_SYSTEM | 3.066 [2.48, 3.79] | < 0.001 |
| Birth year | 0.983 [0.97, 0.99] | 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 242 out of 3664 males with Q17_CONGEN_MALFO_NERVOUS_SYSTEM died.
Mortality risk
Mortality risk for people of age
years, who have Q17_CONGEN_MALFO_NERVOUS_SYSTEM.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.247% | 0.659% |
| 5 | 1.631% | 3.359% |
| 10 | 3.77% | 7.849% |
| 15 | 7.188% | 14.821% |
| 20 | 12.271% | 23.606% |
Relationships between endpoints
↥Index endpoint: Q17_CONGEN_MALFO_NERVOUS_SYSTEM – Congenital malformations of the nervous system
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data